Peroxitech is a biotech start-up out of the University of Pennsylvania. Our lead program is a breakthrough treatment for acute lung injury. The most pressing indication for our lead candidate is...
Total raised: $25M
Investors 1
| Date | Name | Website |
| 02.11.2022 | Xontogeny | xontogeny.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.12.2022 | Series A | $25M | - |
Mentions in press and media 3
| Date | Title | Description |
| 30.01.2023 | Money Moves: Palvella Therapeutics’ Series D, Startup Bucks’ investments and more Philly raises | Money Moves is a column where we chart the funding raises of tech companies across the region. Have a tip? Email us at philly@technical.ly. Palvella Therapeutics’ Series D Palvella Therapeutics, a Berwyn-based late clinical stage biopharma ... |
| 13.12.2022 | Peroxitech Closes $25M Series A Financing | Peroxitech, a Philadelphia, PA-based biopharmaceutical company, raised $25M in Series A funding. The round was led by Perceptive Xontogeny Venture Fund. The company intends to use the funds to build upon the preclinical work conducted throu... |
| - | Peroxitech Therapeutics | - |